Your search returned 711 results.

Results
	1.	Renal function abnormalities and deferasirox. [electronic resource] by Kattamis, Antonis Producer: 20200424 In: The Lancet. Child & adolescent health vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Transfusional Iron Chelation Inches Forward. [electronic resource] by Hagar, Robert Ward Producer: 20200206 In: Acta haematologica vol. 142 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A theoretical study on the electronic structures and equilibrium constants evaluation of Deferasirox iron complexes. [electronic resource] by Salehi, Samie Saljooghi, Amir Shokooh Izadyar, Mohammad Producer: 20170907 In: Computational biology and chemistry vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature. [electronic resource] by Cilloni, Daniela Andreani, Giacomo Dragani, Matteo De Gobbi, Marco Saglio, Giuseppe Producer: 20210427 In: Leukemia & lymphoma vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds? Author's response. [electronic resource] by Kontoghiorghes, G J Producer: 20140402 In: Expert opinion on drug safety vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	6.	A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds? [electronic resource] by Riva, Alessandro Producer: 20140402 In: Expert opinion on drug safety vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy. [electronic resource] by Ikuta, Katsuya Ito, Satoshi Tanaka, Hiroki Sasaki, Katsunori Torimoto, Yoshihiro Fujiya, Mikihiro Kohgo, Yutaka Producer: 20120203 In: Clinica chimica acta; international journal of clinical chemistry vol. 412 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Response to effect of deferasirox on iron absorption in a randomized, placebo-controlled, crossover study in a human model of acute supratherapeutic iron ingestion. [electronic resource] by Parikh, Amay Jang, David H Hoffman, Robert S Howland, Mary Ann Producer: 20110920 In: Annals of emergency medicine vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro-in vivo correlation. [electronic resource] by Al Durdunji, Amal AlKhatib, Hatim S Al-Ghazawi, Mutasim Producer: 20161216 In: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Iron out for nontransfused thalassemia. [electronic resource] by Marks, Peter W Producer: 20121025 In: Blood vol. 120 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Activity of deferasirox in Mucorales: influences of species and exogenous iron. [electronic resource] by Lewis, Russell E Pongas, Georgios N Albert, Nathaniel Ben-Ami, Ronen Walsh, Thomas J Kontoyiannis, Dimitrios P Producer: 20110502 In: Antimicrobial agents and chemotherapy vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Effects of ICL670 (deferasirox) on cardiac iron concentrations. [electronic resource] by Kontoghiorghes, George J Producer: 20051018 In: Lancet (London, England) vol. 366 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	[Deferasirox--a new oral iron chelator--review]. [electronic resource] by Wang, Ting Gao, Chong Chen, Bao-An Producer: 20111013 In: Zhongguo shi yan xue ye xue za zhi vol. 18 Availability: No items available. Save to lists Add to cart (remove)
	14.	Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia. [electronic resource] by Shirley, Matt Plosker, Greg L Producer: 20150525 In: Drugs vol. 74 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Reversal of iron-induced dilated cardiomyopathy during therapy with deferasirox in beta-thalassemia. [electronic resource] by Trad, Omar Hamdan, Mohamed A Jamil, Altaf Khanani, Muhammad F Ishaqi, M Kashif Shamsi, Aisha Hayek, Mohamed Producer: 20090130 In: Pediatric blood & cancer vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Deferasirox: the new oral iron chelator. [electronic resource] by Dubey, A P Sudha, S Parakh, Ankit Producer: 20100225 In: Indian pediatrics vol. 44 Availability: No items available. Save to lists Add to cart (remove)
	17.	Ability of deferasirox to bind iron during measurement of iron. [electronic resource] by Lebitasy, Massin Ampe, Els Hecq, Jean-Daniel Karmani, Linda Nick, Hanspeter Galanti, Laurence Producer: 20100512 In: Clinical chemistry and laboratory medicine vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox. [electronic resource] by Sodagar Taleghani, Arezoo Ebrahimnejad, Pedram Heidarinasab, Amir Akbarzadeh, Azim Producer: 20190610 In: Materials science & engineering. C, Materials for biological applications vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	A Case of Drug-Induced Proximal Tubular Dysfunction. [electronic resource] by Hall, Andrew M Unwin, Robert J Producer: 20201116 In: Clinical journal of the American Society of Nephrology : CJASN vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Deferasirox in pyruvate kinase deficiency. [electronic resource] by Deeren, Dries Producer: 20090401 In: Annals of hematology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 711 results.